Literature DB >> 12794848

New American Academy of Ophthalmology recommendations on screening for hydroxychloroquine retinopathy.

Michael F Marmor.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12794848     DOI: 10.1002/art.10980

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


× No keyword cloud information.
  6 in total

Review 1.  Ocular side effects of anti-rheumatic medications: what a rheumatologist should know.

Authors:  V Peponis; V C Kyttaris; S E Chalkiadakis; S Bonovas; N M Sitaras
Journal:  Lupus       Date:  2010-02-09       Impact factor: 2.911

2.  Spectral-domain optical coherence tomography and adaptive optics may detect hydroxychloroquine retinal toxicity before symptomatic vision loss.

Authors:  Kimberly E Stepien; Dennis P Han; Jonathan Schell; Pooja Godara; Jungtae Rha; Joseph Carroll
Journal:  Trans Am Ophthalmol Soc       Date:  2009-12

3.  The efficacy of antimalarial drugs in the therapy of selected forms of cicatricial alopecia.

Authors:  Martyna A Zbiciak-Nylec; Ligia Brzezińska-Wcisło; Natalia Salwowska
Journal:  Postepy Dermatol Alergol       Date:  2021-05-22       Impact factor: 1.837

Review 4.  Hydroxychloroquine retinopathy.

Authors:  I H Yusuf; S Sharma; R Luqmani; S M Downes
Journal:  Eye (Lond)       Date:  2017-03-10       Impact factor: 3.775

5.  Assessment of hydroxychloroquine maculopathy after cessation of treatment: an optical coherence tomography and multifocal electroretinography study.

Authors:  Marilita M Moschos; Eirini Nitoda; Irini P Chatziralli; Zisis Gatzioufas; Chryssanthi Koutsandrea; George Kitsos
Journal:  Drug Des Devel Ther       Date:  2015-06-11       Impact factor: 4.162

Review 6.  New concepts in antimalarial use and mode of action in dermatology.

Authors:  Sunil Kalia; Jan P Dutz
Journal:  Dermatol Ther       Date:  2007 Jul-Aug       Impact factor: 2.851

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.